Pall Corporation Magnifies Focus on Instrumentation with Expansion of Menlo Park Facility

Thu Jan 10, 2013 1:49pm EST

* Reuters is not responsible for the content in this press release.

California Center of Excellence to Become Design Authority for Pall
Instrumentation Development 
PORT WASHINGTON, N.Y.--(Business Wire)--
Pall Corporation (NYSE:PLL), a global leader in filtration, separation and
purification, today announced that it has expanded its Menlo Park, California
facility, the site of its ForteBio operations, to create a Center of Excellence
(COE) for Instrumentation. The expanded COE, located in the heart of the Silicon
Valley/Bay area, occupies more than 42,000 sq. feet on two floors, which is
nearly double the size of the original facility. The multi-disciplinary center
handles a broad range of functions from instrument and consumable reagent
manufacturing to product development. Acquired by Pall in 2012, ForteBio is a
division of Pall Life Sciences.

"Process instrumentation represents an important growth market for Pall," said
Yves Baratelli, president, Pall Life Sciences. "By creating a center that
focuses on instrumentation and process monitoring system design and development,
we are now better positioned to meet the evolving needs of our research and drug
development customers worldwide. The location of the new COE also will allow us
to capitalize on emerging opportunities in strategic local areas such as the
Silicon Valley region." 

To further demonstrate Pall`s commitment to meeting the widening range of
analytical, testing and monitoring needs of its customers, Pall doubled its
Menlo Park facility`s engineering staff and now operates its Global
Instrumentation Field Service Group from the site. Having the field service,
design engineering and manufacturing teams housed at the same facility will
enable Pall to build greater serviceability into its solutions. The facility
also offers customer training. 

ForteBio`s flagship Octet instrumentation platform and related consumable
reagents, as well as the revolutionary smaller scale BLItz system, continue to
be manufactured at the Menlo Park facility. The BLItz system enables scientists
to easily and cost-effectively conduct label-free analyses of proteins using
small sample volumes right at their lab bench. 

Additional activities being performed at the site include manufacturing of the
Pall Micro-24 MicroReactor process development system for cell culture and
leading-edge software development related to Pall`s GeneDisc pathogen detection

While the current focus of the COE is on life sciences applications, Pall plans
to make the COE an authority on all Pall instrumentation design and development

About Pall Life Sciences 

Pall Life Sciences provides cutting-edge products and services to meet the
demanding needs of customers discovering, developing and producing biotech
drugs, vaccines and classic pharmaceuticals. Pall`s membranes and membrane
devices optimize detection and sample preparation in the drug research, clinical
diagnostics, genomics, and proteomics markets. Pall is a leading provider of
separation systems and single-use filtration and purification technologies to
pharmaceutical and biotechnology companies to support faster development of new
drugs and vaccines that are safer and require less energy and water to produce.
Pall technologies are also used in clinical institutions and the food and
beverage industries. 

About Pall Corporation
Pall Corporation (NYSE:PLL) is a filtration, separation and purification leader
providing solutions to meet the critical fluid management needs of customers
across the broad spectrum of life sciences and industry. Pall works with
customers to advance health, safety and environmentally responsible
technologies. The company`s engineered products enable process and product
innovation and minimize emissions and waste. Pall Corporation is an S&P 500
company serving customers worldwide. Pall has been named a "top green company"
by Newsweek magazine. To see how Pall is helping enable a greener, safer, more
sustainable future, follow us on Twitter @PallCorporation or visit

Doug Novarro
Pall Corporation
Corporate Public Relations
Follow us on Twitter @pallcorporation 

Copyright Business Wire 2013
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.